+ VIEW FULL
A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalas...
Our discovery platform is an exceptionally
rich source of novel protein therapies to
treat patients with life-threatening and
[ Sotatercept ]
[ ACE-536 ]
[ Dalantercept ]